Sajithkumar Akhil, Shenoy Mahesh, Vinod K Rb, Nadakkavukkaran Davis
Chief Dental Surgeon, White Petals Dental Clinic, Pampakuda, Ernakulam, Kerala, India.
Department of OMFS and Diagnostic Services, College of Dentistry, Riyadh Elm University, Riyadh, Saudi Arabia.
J Oral Maxillofac Pathol. 2025 Jan-Mar;29(1):127-136. doi: 10.4103/jomfp.jomfp_187_24. Epub 2025 Mar 28.
Developments in tissue engineering, diagnosis, and therapy of oral diseases can be made possible by nanotechnology. The purpose of this scoping review was to assess the state of nanotechnology applications in oral pathology at the moment. A thorough search for research published between 2000 and 2024 was done using various online data bases. Relevant studies were identified, screened, and included in accordance with the Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) guidelines standards as per the selection criterion. A total of 57 studies satisfied the requirements for inclusion. Significant findings show that in oral disease, nanotechnology greatly enhances treatment delivery, regeneration capacity, and diagnostic accuracy. Among the most promising tools identified were nanofibers, liposomes, quantum dots, and gold nanoparticles. In the field of oral pathology, nanotechnology has great potential for novel approaches to early diagnosis, targeted therapy, and tissue regeneration. However, additional investigation are needed to solve safety and biocompatibility challenges.
纳米技术能够推动口腔疾病组织工程、诊断及治疗领域的发展。本综述的目的是评估目前纳米技术在口腔病理学中的应用状况。通过多个在线数据库,对2000年至2024年间发表的研究进行了全面检索。按照系统评价和Meta分析的首选报告项目(PRISMA)指南标准及选择标准,确定、筛选并纳入了相关研究。共有57项研究符合纳入要求。重要发现表明,在口腔疾病中,纳米技术极大地提高了治疗效果、再生能力及诊断准确性。其中最具潜力的工具包括纳米纤维、脂质体、量子点和金纳米颗粒。在口腔病理学领域,纳米技术在早期诊断、靶向治疗和组织再生的新方法方面具有巨大潜力。然而,还需要进一步研究以解决安全性和生物相容性方面的挑战。
J Oral Maxillofac Pathol. 2025
Cochrane Database Syst Rev. 2022-2-1
Early Hum Dev. 2020-11
Chem Soc Rev. 2024-4-22
Curr Top Med Chem. 2021
JBI Database System Rev Implement Rep. 2019-12
Clin Exp Med. 2024-1-19
J Funct Biomater. 2023-11-11
Molecules. 2023-9-14
Adv Pharm Bull. 2023-1
Bioengineering (Basel). 2022-9-1